Last updated: November 16, 2023
Sponsor: Sheba Medical Center
Overall Status: Active - Recruiting
Phase
N/A
Condition
In Vitro Fertilization
Treatment
Sexual intercourse
Clinical Study ID
NCT06134609
SMC-0653-23
Ages 18-41 Female Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Women age 18-41yrs.
- BMI (body mass index) of 18-35 kg/m².
- Patients undergoing one of their first four frozen embryo transfers.
- Patients transferring a good quality embryo, either a cleavage stage embryo or a day 5blastocyst.
Exclusion
Exclusion Criteria:
- Patients age above 42.
- Moderate or poor-quality embryos.
- Patients with hydrosalpinx or uterus malformations.
- Patients who are not able or are not interested in having vaginal intercourse (samesex couples for example).
- Couples undergoing preimplantation genetic diagnosis when natural cycle frozen embryotransfer is planned (as they are instructed to avoid intercourse).
Study Design
Total Participants: 656
Treatment Group(s): 1
Primary Treatment: Sexual intercourse
Phase:
Study Start date:
November 13, 2023
Estimated Completion Date:
November 30, 2026
Study Description
Connect with a study center
Sheba Medical Center
Ramat Gan,
IsraelActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.